|
|
||||||||
ligand and receptor expression in
neonatal rat lungs exposed to chronic hypoxia
1 Section of Respiratory Medicine, Department of Pediatrics, and 2 Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06512-8023
| |
ABSTRACT |
|---|
|
|
|---|
Long-term effects of hypoxia are
largely due to its modulatory effects on proliferation and
differentiation of epithelial and endothelial cells, processes also
regulated by the transforming growth factor (TGF)-
system.
We investigated the effects of hypoxia on the TGF-
system in rat
lungs from different developmental stages. Sprague-Dawley rats were
exposed to 9.5% oxygen during either the first 2 wk of life or
adulthood. Analysis revealed an arrest of alveolarization in hypoxic
postnatal day 14 rats. Bioactive TGF-
levels in
bronchoalveolar lavage fluid were increased in these animals, and
Western blot analysis revealed upregulation of TGF-
receptor (T
R)
I and II. None of these changes was observed in hypoxic adults. Hypoxia
did, however, lead to decreased expression of T
RIII in both
postnatal day 14 and adult rats. Immunohistochemical analysis localized T
RI-III predominantly to bronchiolar and alveolar epithelium; these patterns did not change with hypoxia. Thus we observed changes in TGF-
activity and T
R isotype expression in
rat lung that parallel the arrest in alveolarization seen with chronic
hypoxia in early development. These alterations may partly explain the
morphological changes observed in hypoxia.
transforming growth factor-
; lung development; alveolarization; transforming growth factor-
receptor; betaglycan
| |
INTRODUCTION |
|---|
|
|
|---|
POSTNATAL LUNG DEVELOPMENT involves the formation of alveoli from existing but immature respiratory saccules by means of septation, maturation of epithelial and mesenchymal units, and development of the alveolar capillary system (4, 21). In rats, alveolar septation begins at postnatal days (P) 3-4 and continues throughout the second week of postnatal development. Maturation of newly formed units occurs in parallel and continues throughout the fourth week of postnatal lung development. These processes are tightly regulated by direct interactions between epithelial and mesenchymal cells (5).
Several intrinsic and extrinsic factors have been identified as modifiers of postnatal lung growth. For example, hypoxia over prolonged periods can affect lung growth (27). There has been some controversy, however, regarding the overall effects of hypoxia on the postnatal development of the lung (3, 22). Whether such issues are related to age or stage of development at the time of exposure is not well defined, and possible mediators of the effects of hypoxia on lung morphology remain essentially unexplored.
Whereas the molecular mechanisms underlying the effects of hypoxia on
lung growth remain to be delineated, significant advances have been
made in our understanding of the mediators controlling prenatal lung
morphogenesis and branching. Members of the transforming growth factor
(TGF)-
family have emerged as crucial factors controlling the
formation, patterning, and maturation of lung tissue (13, 24). TGF-
belongs to a superfamily of polypeptides including 1) TGF-
isoforms themselves, 2) activins, and
3) a complex third subfamily consisting of morphogenic
proteins (bone morphogenic proteins, nodal, Xenopus Vg-1,
Drosophila dpp, and screw). On most cell types studied,
three classes of receptors for TGF-
(T
R) have been identified:
the type I (T
RI), type II (T
RII), and type III (T
RIII)
receptors. Biological responses to TGF-
are induced on binding of
activated TGF-
ligand to T
RII, which induces the formation of a
heterooligomeric complex of T
RI and T
RII. T
RI is then
phosphorylated by the constitutively active kinase domain of T
RII,
and downstream signaling is initiated (20, 25). TGF-
is
an important regulator of cellular differentiation and proliferation in
the lung (e.g., by inhibition of epithelial cell proliferation, or
induction of mesenchymal cell proliferation) and thus represents an
important candidate in the control of lung development and growth.
Furthermore, early lung branching is inhibited by TGF-
(31,
32), providing functional evidence for a key role of TGF-
as
a negative regulator of lung branching and prenatal lung development.
Little is known, however, about the regulation of TGF-
activity and
the expression patterns of T
Rs in the lung and whether they are
affected by low-O2 conditions. In this study, we,
therefore, investigated the effects of chronic hypoxia on postnatal
lung development, with a focus on characterization of the TGF-
system under normal and low-O2 conditions.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Study animals. Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) were placed into 9.5% oxygen at P3 and reared in hypoxia until P14. For each set of experiments, litters were trimmed to eight pups to minimize confounding variables related to litter size and lung growth. Weights of P14 hypoxic animals were reduced by ~54% compared with controls (14.7 ± 1.2 vs. 34.1 ± 1.12 g), whereas there was no weight difference in the adult rats. Other observations, such as enlargement of the right ventricle, were present in both hypoxic P14 and adult animals (data not shown). In rare instances, pups from the hypoxic P14 group died, whereas all animals in the remaining groups survived. No data were generated from dead or moribund animals. Similarly, adult rats raised in room air were placed into 9.5% oxygen for 2 wk before death with their normoxic controls. The adult rats examined were separate animals and not the mothers of the neonatal litters exposed. At the end of each experimental period, hypoxic and control rats were anesthetized and killed, as approved by Animal Services. Lung tissue was harvested, rinsed, and immediately frozen in dry ice. All experimental groups were housed in pathogen-free chambers and monitored daily for any signs of infection by the Animal Services Facility of Yale University School of Medicine.
Lung processing and histological analysis. In selected animals from each experimental group, lungs were inflated through tracheotomies to 20 cmH2O pressure with 4% paraformaldehyde (pH 7.4), and tracheas were ligated. Lungs and hearts were excised en bloc, submersed in 4% paraformaldehyde overnight, and processed by Research Histology (Critical Technologies Program, Dept. Pathology, Yale University) for paraffin embedding and sectioning. Lung tissues were cut into 3-µm sections and stained with Trichrome. The degree of alveolar septation was analyzed under light microscopy with a 1 × 1 mm grid at ×200 magnification. The grid was divided into 11 equally spaced horizontal lines; each septum, which crossed the horizontal lines, was counted. A total of 10 separate grids from three randomly selected animals was analyzed for each slide, and the average number of septae per grid was calculated. Similarly, septal thickness was analyzed with the Image Pro software. In brief, slides were examined at ×500 magnification under a grid of five equally spaced horizontal lines. Each grid examined consisted solely of alveolar tissue; bronchioles were intentionally omitted from the field of view. The thickness of each septum crossing a given horizontal line was measured perpendicular to its course at that crossing point. A total of 10 separate grids from three randomly selected animals was analyzed, and the average septal thickness was then calculated for each grid.
Collection of bronchoalveolar lavage fluid.
Tracheotomies were performed in selected animals from each experimental
group, and tracheas were cannulated with an appropriately sized
catheter. Lungs were lavaged with either 1 ml (P14 animals) or 3 ml
(adult animals) of PBS (pH 7.4) and immediately frozen in
70°C.
Protein concentration was equalized by using the Bradford assay
according to the manufacturer's instructions.
Luciferase assay for TGF-
activity.
Active TGF-
levels in bronchoalveolar lavage fluid (BALF) were
measured by using the p3TP-Lux reporter construct and MvLu1 cells, as
described previously (1). Briefly, BALF was obtained from
three different animals of each experimental group, as indicated. MvLu1
cells transfected with the TGF-
responsive reporter p3TP-Lux were
then incubated in DMEM containing 1% fetal bovine serum, 10 mM HEPES,
and 20% of each respective BALF for 24 h. Supernatants were
removed, and Luciferase activity was measured in total cell lysates
after 24 h. Luciferase activities were normalized by transfection controls, as described (11). To investigate the
contribution of each of the three TGF-
isoforms
(TGF-
1, TGF-
2, and TGF-
3) to BALF-induced p3TP-Lux statement, each sample was preincubated with
the respective isoform-specific neutralizing anti-TGF-
antibody in a separate set of experiments, as recommended by the manufacturer (R&D Systems), before and during incubation of the BALF sample on MvLu1 cells.
Western blot analysis.
Frozen lung tissue was homogenized by using a tissue grinder in
lysis buffer consisting of 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, and 1 mM
-glycerophosphate. The proteinase inhibitor Complete (Roche
Molecular Biochemicals, Indianapolis, IN) and
Na3VO4 (2 mM) were added to the lysis buffer
immediately before homogenization. Homogenates were sheared by multiple
aspiration through a 24-gauge needle, agitated at 4°C for 30 min, and
centrifuged at 15,000 rpm (4°C) for 10 min. Supernatants were taken
as whole tissue lysates, and protein concentration was measured by
using the Bradford assay according to the manufacturer's instructions.
Equal amounts of protein (4 µg) were separated on 7.5% SDS-PAGE gels
and transferred to nitrocellulose, as described earlier
(10). Western blots were performed with antibodies against
constitutive heat shock cognate 70 (HSC70; 1:5,000; Stressgen,
Victoria, BC), T
RI (1:1,000; Santa Cruz Biotechnologies, Santa Cruz,
CA), T
RII (1:1,000; Santa Cruz Biotechnologies), and T
RIII
(betaglycan; 1:500; R&D Systems). Specific bands were visualized after
incubation with the respective secondary antibodies by autoradiography
by using enhanced chemiluminescence, according to the manufacturer
(SuperSignal, Pierce Chemicals, Rockford, IL). Specificity of primary
antibodies was assessed by incubation with their respective blocking peptides.
Densitometry measurements.
Densitometry measurements of Western blots from each experimental group
were obtained (n
6 for each group), and absolute values
were equalized with constitutive HSC70.
Immunohistochemical analysis.
Lung tissue sections were deparaffinized in xylene for 3 × 5 min and
rehydrated in 100% ethanol for 2 × 10 min, 95% ethanol for 2 × 10 min, and distilled water for 1 × 5 min. Antigen retrireview was
performed in a pressure cooker using 6.5 mM sodium citrate (pH 6.0).
Immunohistochemical analysis was performed by using the indicated
primary antibodies at 1:50 dilutions. Immunoreactivity was
detected by avidin-biotin complex staining according to the manufacturer's instructions (Santa Cruz Biotechnologies). Endogenous peroxidase activity was quenched by incubating the sections in 1.5%
hydrogen peroxidase-methanol for 10 min. Specificity was assessed
through staining of control sections with primary antibodies in the
presence of their respective blocking peptides. Because blocking
peptides for T
RIII were not available, negative control slides for
T
RIII were generated by incubation in the presence of a
species-corresponding, unspecific primary antibody. Peroxidase-labeled sections were counterstained with hematoxylin-eosin for 10 s.
| |
RESULTS |
|---|
|
|
|---|
Morphological and histological changes in rat lungs exposed to
hypoxia.
Exposure of rats to chronic hypoxia dramatically affected normal
postnatal development of the lung (Fig.
1). Histological examination of lungs
obtained from hypoxic rats at P14 (Fig. 1D) revealed a
remarkable arrest of alveolarization compared with their normoxic
controls (Fig. 1B). Furthermore, lungs from hypoxic animals
at P14 showed little progression in development compared with newborn
animals, with a predominance of terminal saccules in peripheral tissue
rather than the well-formed alveoli seen in normoxic controls. In
comparison, lung tissue from adult rats exposed to hypoxia (Fig.
1E) showed no obvious differences compared with their
normoxic controls (Fig. 1C). Quantitative analysis of septal
number and thickness demonstrated a significant reduction in average
septal number per grid in hypoxic animals at P14 compared with controls
(71 ± 8.34 vs. 87.4 ± 6.6 septae/grid, P < 0.005). In adult animals, consistent with histological data, we found no statistically significant differences (92 ± 7.4 vs. 80.8 ± 7.84 septae/grid for hypoxia vs. normoxia). Similar results were obtained when we quantified the average septal thickness. In lungs from
hypoxic animals at P14, septal thickness was reduced by >45% compared
with control lungs (5.28 ± 0.55 vs. 9.56 ± 2.17 µm,
P < 0.001). In adult animals, average septal
thickness was not significantly altered when the animals were exposed
to chronic hypoxia (4.42 ± 0.35 vs. 4.56 ± 0.19 µm).
|
Measurement of bioactive TGF-
in hypoxic rat lungs.
Hypoxia affected lung morphology specifically during the period of
alveolar development, where it led to an arrest of alveolarization. Because the TGF-
system functions as a potent inhibitor of
prenatal lung development, we sought to analyze bioactive TGF-
levels in rat lungs using a TGF-
-sensitive assay (1).
As depicted in Fig. 2A, active
TGF-
levels were significantly increased in BALF obtained from
hypoxic animals at P14, compared with their normoxic controls
(1,120 ± 153 vs. 510 ± 130 relative light units, P < 0.02). Interestingly, we found no statistically
significant differences in TGF-
bioactivity in BALF when comparing
hypoxic and normoxic adult rats (Fig. 2A). The Luciferase
construct used to measure TGF-
bioactivity, p3TP-Lux, is similarly
responsive to all three TGF-
isoforms. Therefore, we performed
additional reporter gene experiments after incubation of BALF samples
with isoform-specific, neutralizing antibodies directed against
TGF-
1, TGF-
2, or TGF-
3.
Figure 2B demonstrates that the greater than twofold
increase in bioactive TGF-
levels observed in BALF from P14 hypoxic
rats is abrogated by coincubation with anti-TGF-
1 and
anti-TGF-
2 antibodies (P < 0.05),
whereas incubation with anti-TGF-
3 antibody did not
result in a significant decrease. The greatest part of TGF-
bioactivity in hypoxic BALF samples can, therefore, be attributed to
the presence of TGF-
1 and TGF-
2 isoforms.
|
Statement of T
R in hypoxic rat lungs.
Because chronic hypoxia resulted in increased TGF-
activity in BALF
samples at P14 but not in adults, we further analyzed the expression
patterns of T
Rs in hypoxic and control lungs to determine whether
hypoxia exerted complementary changes in receptor expression. Western
blot analysis revealed the presence of all three receptors, T
RI,
T
RII, and T
RIII, at the expected sizes in whole lung extracts
(Fig. 3A). Chronic hypoxia led
to a dramatic upregulation of T
RI in the P14 group (Fig.
3A, lanes 1-4). Further analysis of this
effect by densitometry demonstrated that this upregulation was fourfold
above the expression levels seen in normoxic animals (Fig.
3B). Interestingly, this upregulation of T
RI expression
was not observed in adult animals (Fig. 3A, lanes 5-8). Here, densitometry measurements revealed no significant changes in T
RI expression (Fig. 3B). Similar to T
RI,
T
RII expression was upregulated at P14 with hypoxia (Fig.
3A, lanes 1-4). Densitometry revealed that
the increase in expression was ~30-35% above control levels
(Fig. 3B). In adult animals, hypoxia caused no significant difference in T
RII expression (Fig. 3A, lanes
5-8). Different observations were made, however, for
T
RIII. T
RIII expression was dramatically downregulated in
response to hypoxia, both at P14 (Fig. 3A, lanes
1-4) and in adult animals (Fig. 3A, lanes 5-8), which was confirmed by densitometry (Fig.
3B).
|
Localization of T
R in rat lungs.
Because we observed major changes in the expression levels of
T
Rs in response to hypoxia, specifically in P14 animals, we further
studied the localization patterns of these receptors in hypoxic and
normoxic lungs from animals at this age. Immunohistochemical analysis
of lung tissue obtained from P14 rats demonstrated that all three
receptors were predominantly localized to bronchiolar epithelium of
larger airways and alveolar tissue (Fig.
4, A-C, arrows). Less intense
signals were also noted in endothelial cells. Consistent with Western
blot data, the staining for T
RI and T
RII appeared to be more
intense in hypoxic lungs (Fig. 4, D and E), particularly in alveolar tissue. Similarly, the staining for T
RIII was less intense in hypoxic tissues (Fig. 4F) compared with
normoxic tissues. Of note, smooth muscle cells stained only weakly for all three receptors. To assess antibody specificity for T
RI and T
RII, hypoxic slides were also stained after incubation of the primary anti-T
RI and anti-T
RIII antibodies with their
corresponding blocking peptides (Fig. 4, G and H,
respectively). A blocking peptide for the T
RIII antibody was not
available, as such; control stainings for this receptor were performed
by using species-corresponding, unspecific primary antibody. These
experiments clearly demonstrated the specificity of our stainings (Fig.
4, G and H).
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we characterized the effects of chronic
hypoxia on TGF-
and T
R isotype expression in rat lungs obtained from P14 and adult animals. We found that bioactive TGF-
levels, as
well as the expression levels of the receptor isotypes T
RI and
T
RII, were increased in hypoxia. These effects of hypoxia on TGF-
activity and T
R expression were age dependent; they were only
observed early in postnatal development but not in adult animals.
Interestingly, the overall increase in TGF-
activity was observed at
a developmental stage when hypoxia led to an arrest in alveolar
development (Fig. 1 and Refs. 3, 22). These
different responses to hypoxia at two distinct stages of development
imply that specific and possibly different regulatory mechanisms
control lung development and morphology at these specified ages. The
molecular mechanisms underlying such differences, however, have thus
far remained obscure. Importantly, we were able to perform the
histological and molecular analyses simultaneously in identical
animals. Hence, we had an ideal opportunity to concurrently investigate
both the morphological changes induced by chronic hypoxia, as well as
the potential mechanisms underlying these alterations in structure.
With respect to morphology, hypoxia clearly affected normal postnatal
lung development. Because we could demonstrate major changes in the
TGF-
system in response to hypoxia, we believe that these changes
can explain, at least in part, the observed lung phenotype for three
major reasons. First, an increase in bioactive TGF-
ligand was
observed only in P14 animals exposed to hypoxia, and only P14 animals
exhibited the described morphological changes with hypoxia. Indeed, it
has been shown that prenatal lung branching in vitro is inhibited by
TGF-
signaling (31, 32). Although our present study
focuses on the effects of hypoxia during postnatal life, these past
investigations, nevertheless, provide functional evidence that TGF-
is a negative regulator of lung morphogenesis. Interestingly, adult
animals exposed to hypoxia did not show any differences in TGF-
activity, coinciding with the fact that alveolar morphology was not
altered with hypoxia at this age. It is important to note, however,
that our study did not rely on measurements of total TGF-
in BALF,
because there is a large amount of inactive TGF-
in biological
samples, e.g., pools deposited within the extracellular matrix
(2, 20, 26).
Second, we found a major upregulation in T
RI and, to a lesser
degree, T
RII expression in hypoxic P14 animals. This, in combination with the increased levels of bioactive TGF-
, would lead to an overall upregulation of the signal transducing components of this system. In addition, although there is significant controversy surrounding the exact role of T
RIII (or betaglycan), there is evidence that, in certain cell types, especially epithelial cells, this
receptor may function as an inhibitor of TGF-
signaling (9). In this respect, it has become increasingly clear
that the cell surface expression of T
Rs, especially T
RI and
T
RII, is able to regulate not only the cellular response to TGF-
,
but also the activation of specific downstream signaling molecules (6-8). Accordingly, the observed upregulation of
T
RI and, to a lesser extent, T
RII expression specifically in
hypoxic P14 animals would result in an increased TGF-
response. The
dramatic downregulation of T
RIII (betaglycan) expression could also
lead to enhanced downstream signaling. The resulting overall response would lead to an arrest in early lung development, either by premature differentiation, inhibition of proliferation, or a combination thereof
(20, 25).
Finally, our observation that all three T
Rs mostly localized to
airway and alveolar epithelial cells, which are ultimately responsible
for the generation of new lung, also supports our belief that the
observed changes in the TGF-
system have an impact on the phenotypic
alterations seen early in development. Indeed, TGF-
is a
well-known inhibitor of epithelial cell proliferation (19,
25). Importantly, the localization of T
RI and T
RII did not
change with hypoxia, but rather became more intense in alveolar cells.
Similarly, the localization of T
RIII did not change, but rather
became less intense in both bronchiolar and alveolar cells.
Although we present data supporting the fact that chronic hypoxia induced the observed morphological changes by directly affecting target cells such as alveolar epithelial cells, we realize that, in vivo, hypoxia also produces a variety of hormonal, nutritional, cardiovascular, and biochemical alterations that may lead indirectly to such morphological changes. Indeed, the decreases in whole body weights of hypoxic P14 animals compared with controls may suggest additional synergisms with nutritional issues. Past investigators, however, have reported that hypoxia induces morphological alterations in the lung that are independent of, although accentuated by, any nutritional differences (27). Therefore, it is possible that, in our model, hypoxia induces its effects directly or indirectly.
Hypoxia is a potent stimulus that causes complex changes in multiple
coexisting signal transduction pathways, which may confound its overall
effect on the lung as a single organ. As such, it will be important to
examine specific regulatory mechanisms of postnatal lung development
and then assess how hypoxia specifically affects these processes. For
example, it is well known that epithelial-mesenchymal interactions are
of crucial importance in controlling lung development (18,
21). During alveologenesis, close interactions of proliferating and differentiating epithelial cells with their surrounding endothelial cells are required for the subsequent proper formation of alveoli. It
follows that, in the case of deficient or improper angiogenesis, the
formation of alveoli is also inhibited, a mechanism that has been
suggested to contribute to diseases such as bronchopulmonary dysplasia
(BPD) or emphysema (14, 28). In this respect, it has
recently been shown that T
RI receptor expression is a major regulator of vascular development. Whereas the activin receptor-like kinase (ALK)-1 isoform of T
RI induces endothelial cell
migration and proliferation, expression of the ALK-5 T
RI isoform
does the reverse (12). In our studies, we have found
dramatic upregulation of the ALK-5 isoform of T
RI in rat lungs
subjected to hypoxia (Fig. 3), which coincided with an arrest of
alveolarization with hypoxia. Therefore, it is clearly possible that
such molecular processes governed by increased TGF-
1 and ALK-5
activities are a major cause for the arrest of alveolarization observed
in our model of hypoxic rat lungs.
Although such speculations are tempting, the exact molecular mechanisms
underlying the hypoxia-induced arrest in alveolarization cannot
entirely be deduced from these studies. Other methods are needed to
answer these questions directly. Ideally, age-specific TGF-
1 overexpression, as well as selective modulation of
lung epithelial cell T
R expression by transgenic technologies, will help to address these questions in the future. At present, only the
selective overexpression of soluble secreted proteins in the lung is a
feasible approach to analyze the morphological effects of growth
factors or cytokines (35). The presented findings, nevertheless, suggest an essential role for the TGF-
system in the
response of lung epithelial cells to chronic hypoxia at different developmental stages.
In this respect, manipulation of TGF-
signaling and/or receptor
expression may become a promising pharmacological target in diseases
involving an arrest or interruption of alveolar development, such as
BPD. Although hyperoxia rather than hypoxia has been implicated in the
pathophysiology of BPD, similar morphologic characteristics (i.e.,
inhibition of alveolarization) have been reported on pathological examination of lung sections from BPD patients, and it remains to be
elucidated whether early hypoxia indeed represents an initial trigger
for disease onset (14, 17, 23). Whereas TGF-
has been
implicated in the pathogenesis of BPD before, a paucity of work exists
in this field (28). Further investigations addressing specific regulatory mechanisms, as well as elucidation of the various
downstream mediators of TGF-
signaling, may help to address the
different phenotypes associated with increased TGF-
activity, both
developmentally and with exposure to hypoxia.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Julie Ryu, Bettina Bidmon, Holger Link, and Miguel Reyes-Mugica for invaluable discussion with this project, as well as Andrea Mann for expert technical advice. We are indebted to Aaron Hochberg and Ralph Garcia for assistance in animal care. Lastly, we are grateful for the continued support of Rose Anne Mallon and Dr. Christiane Eickelberg.
| |
FOOTNOTES |
|---|
This study was supported by National Institutes of Health (NIH) Grants 5P01HD-32573 and 1R01HL-66327 (to G. G. Haddad), NIH Training Grant T32HL-07272 (to George Lister, Yale University, Department of Pediatrics), and Juvenile Diabetes Foundation International Grant 10-2000-71 (to O. Eickelberg).
Present address of O. Eickelberg: University of Giessen School of Medicine, Department of Medicine II, Aulweg 123, 35392 Giessen, Germany.
Address for reprint requests and other correspondence: G. G. Haddad, Yale Univ. School of Medicine, Dept. of Pediatrics, Section of Respiratory Medicine, Fitkin 507, 333 Cedar St., P. O. Box 208064, New Haven, CT 06520-8064 (E-mail: gabriel.haddad{at}yale.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
May 3, 2002;10.1152/japplphysiol.00031.2002
Received 15 January 2002; accepted in final form 30 April 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abe, M,
Harpel JG,
Metz CN,
Nunes I,
Loskutoff DJ,
and
Rifkin DB.
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
Anal Biochem
216:
276-284,
1994[ISI][Medline].
2.
Behzadian, MA,
Wang XL,
Shabrawey M,
and
Caldwell RB.
Effects of hypoxia on glial cell statement of angiogenesis-regulating factors VEGF and TGF-beta.
Glia
24:
216-225,
1998[ISI][Medline].
3.
Blanco, LN,
Massaro D,
and
Massaro GD.
Alveolar size, number, and surface area: developmentally dependent response to 13% O2.
Am J Physiol Lung Cell Mol Physiol
261:
L370-L377,
1991
4.
Burri, PH.
Fetal and postnatal development of the lung.
Annu Rev Physiol
46:
617-628,
1984[ISI][Medline].
5.
Burri, PH,
Dbaly J,
and
Weibel ER.
The postnatal growth of the rat lung. I. Morphometry.
Anat Rec
178:
711-730,
1974[Medline].
6.
Carcamo, J,
Weis FM,
Ventura F,
Wieser R,
Wrana JL,
Attisano L,
and
Massague J.
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Mol Cell Biol
14:
3810-3821,
1994
7.
Centrella, M,
Casinghino S,
Kim J,
Pham T,
Rosen V,
Wozney J,
and
McCarthy TL.
Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel statement of the osteoblast phenotype.
Mol Cell Biol
15:
3273-3281,
1995[Abstract].
8.
Chen, RH,
Ebner R,
and
Derynck R.
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
Science
260:
1335-1338,
1993
9.
Eickelberg, O,
Centrella M,
Reiss M,
Kashgarian M,
and
Wells RG.
Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function.
J Biol Chem
277:
823-829,
2002
10.
Eickelberg, O,
Kohler E,
Reichenberger F,
Bertschin S,
Woodtli T,
Erne P,
Perruchoud AP,
and
Roth M.
Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-
1 and TGF-
3.
Am J Physiol Lung Cell Mol Physiol
276:
L814-L824,
1999
11.
Eickelberg, O,
Pansky A,
Koehler E,
Bihl M,
Tamm M,
Hildebrand P,
Perruchoud AP,
Kashgarian M,
and
Roth M.
Molecular mechanisms of TGF-
antagonism by interferon
and cyclosporine A in lung fibroblasts.
FASEB J
15:
797-806,
2001
12.
Goumans, MJ,
Valdimarsdottir G,
Itoh S,
Rosendahl A,
Sideras P,
and
ten Dijke P.
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
EMBO J
21:
1743-1753,
2002[ISI][Medline].
13.
Heine, UI,
Munoz EF,
Flanders KC,
Roberts AB,
and
Sporn MB.
Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis.
Development
109:
29-36,
1990[Abstract].
14.
Husain, AN,
Siddiqui NH,
and
Stocker JT.
Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.
Hum Pathol
29:
710-717,
1998[ISI][Medline].
15.
Ji, C,
Casinghino S,
McCarthy TL,
and
Centrella M.
Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor.
J Biol Chem
272:
21260-21267,
1997
16.
Ji, C,
Chen Y,
McCarthy TL,
and
Centrella M.
Cloning the promoter for transforming growth factor-beta type III receptor. Basal and conditional statement in fetal rat osteoblasts.
J Biol Chem
274:
30487-30494,
1999
17.
Jobe, AH,
and
Ikegami M.
Lung development and function in preterm infants in the surfactant treatment era.
Annu Rev Physiol
62:
825-846,
2000[ISI][Medline].
18.
Maeda, S,
Suzuki S,
Suzuki T,
Endo M,
Moriya T,
Chida M,
Kondo T,
and
Sasano H.
Analysis of intrapulmonary vessels and epithelial-endothelial interactions in the human developing lung.
Lab Invest
82:
293-301,
2002[ISI][Medline].
19.
Massague, J.
How cells read TGF-beta signals.
Nat Rev Mol Cell Biol
1:
169-178,
2000[ISI][Medline].
20.
Massague, J.
TGF-beta signal transduction.
Annu Rev Biochem
67:
753-791,
1998[ISI][Medline].
21.
Massaro, GD,
and
Massaro D.
Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation.
Annu Rev Physiol
58:
73-92,
1996[ISI][Medline].
22.
Massaro, GD,
Olivier J,
Dzikowski C,
and
Massaro D.
Postnatal development of lung alveoli: suppression by 13% O2 and a critical period.
Am J Physiol Lung Cell Mol Physiol
258:
L321-L327,
1990
23.
O'Reilly, MA,
Staversky RJ,
Flanders KC,
Johnston CJ,
and
Finkelstein JN.
Temporal changes in statement of TGF-beta isoforms in mouse lung exposed to oxygen.
Am J Physiol Lung Cell Mol Physiol
272:
L60-L67,
1997
24.
Pelton, RW,
Saxena B,
Jones M,
Moses HL,
and
Gold LI.
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: statement patterns suggest multiple roles during embryonic development.
J Cell Biol
115:
1091-1105,
1991
25.
Piek, E,
Heldin CH,
and
Ten Dijke P.
Specificity, diversity, and regulation in TGF-
superfamily signaling.
FASEB J
13:
2105-2124,
1999
26.
Roberts, AB.
Molecular and cell biology of TGF-beta.
Miner Electrolyte Metab
24:
111-119,
1998[ISI][Medline].
27.
Sekhon, HS,
and
Thurlbeck WM.
Lung morphometric changes after exposure to hypobaria and/or hypoxia and undernutrition.
Respir Physiol
106:
99-107,
1996[ISI][Medline].
28.
Toti, P,
Buonocore G,
Tanganelli P,
Catella AM,
Palmeri ML,
Vatti R,
and
Seemayer TA.
Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study.
Pediatr Pulmonol
24:
22-28,
1997[ISI][Medline].
29.
Ulloa, L,
Doody J,
and
Massague J.
Inhibition of transforming growth factor-beta/SMAD signaling by the interferon-gamma/STAT pathway.
Nature
397:
710-713,
1999[Medline].
30.
Wang, XF,
Lin HY,
Ng-Eaton E,
Downward J,
Lodish HF,
and
Weinberg RA.
Statement cloning and characterization of the TGF-beta type III receptor.
Cell
67:
797-805,
1991[ISI][Medline].
31.
Zhao, J,
Crowe DL,
Castillo C,
Wuenschell C,
Chai Y,
and
Warburton D.
Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Mech Dev
93:
71-81,
2000[ISI][Medline].
32.
Zhao, J,
Shi W,
Chen H,
and
Warburton D.
Smad7 and Smad6 differentially modulate transforming growth factor beta-induced inhibition of embryonic lung morphogenesis.
J Biol Chem
275:
23992-23997,
2000
33.
Zhao, Y,
and
Young SL.
Statement of transforming growth factor-beta type II receptor in rat lung is regulated during development.
Am J Physiol Lung Cell Mol Physiol
269:
L419-L426,
1995
34.
Zhao, Y,
Young SL,
McIntosh JC,
Steele MP,
and
Silbajoris R.
Ontogeny and localization of TGF-beta type I receptor statement during lung development.
Am J Physiol Lung Cell Mol Physiol
278:
L1231-L1239,
2000
35.
Zhu, Z,
Ma B,
Homer RJ,
Zheng T,
and
Elias JA.
Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overstatement transgenic mice.
J Biol Chem
276:
25222-25229,
2001
36.
Ziesche, R,
Hofbauer E,
Wittmann K,
Petkov V,
and
Block LH.
A preliminary study of long-term treatment with interferon
-1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis.
N Engl J Med
341:
1264-1269,
1999
This article has been cited by other articles:
![]() |
N. Ambalavanan, T. Nicola, J. Hagood, A. Bulger, R. Serra, J. Murphy-Ullrich, S. Oparil, and Y.-F. Chen Transforming growth factor-{beta} signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L86 - L95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Alejandre-Alcazar, G. Kwapiszewska, I. Reiss, O. V. Amarie, L. M. Marsh, J. Sevilla-Perez, M. Wygrecka, B. Eul, S. Kobrich, M. Hesse, et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L537 - L549. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, D. Zhou, A. G. Vicencio, J. Ryu, J. Xue, A. Kanaan, O. Gavrialov, and G. G. Haddad Effect of carbon dioxide on neonatal mouse lung: a genomic approach J Appl Physiol, December 1, 2006; 101(6): 1556 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shigemura, Y. Sawa, S. Mizuno, M. Ono, M. Minami, M. Okumura, T. Nakamura, Y. Kaneda, and H. Matsuda Induction of Compensatory Lung Growth in Pulmonary Emphysema Improves Surgical Outcomes in Rats Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1237 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Vicencio, C. G. Lee, S. J. Cho, O. Eickelberg, Y. Chuu, G. G. Haddad, and J. A. Elias Conditional Overexpression of Bioactive Transforming Growth Factor-{beta}1 in Neonatal Mouse Lung: A New Model for Bronchopulmonary Dysplasia? Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 650 - 656. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |